Proto-Oncogene Proteins c-mdm2, antagonists & inhibitors
- Name
- Proto-Oncogene Proteins c-mdm2, antagonists & inhibitors
- Accession Number
- DBCAT003206
- Description
Not Available
- Drugs
Drug Drug Description Idasanutlin Idasanutlin has been used in trials studying the treatment of Neoplasms, Non-Hodgkin's Lymphoma, Leukemia, Myeloid, Acute, Recurrent Plasma Cell Myeloma, and Neoplasms, Leukemia, Acute Myeloid Leukemia. - Drugs & Drug Targets
Drug Target Type